There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Arcadia Biosciences (RKDA – Research Report) and Sierra Metals (SMTS – Research Report) with bullish sentiments.
Arcadia Biosciences (RKDA)
In a report released today, Ben Klieve from Lake Street reiterated a Buy rating on Arcadia Biosciences, with a price target of $3.50. The company’s shares closed last Thursday at $0.85, close to its 52-week low of $0.74.
According to TipRanks.com, Klieve is ranked #369 out of 7855 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Arcadia Biosciences with a $3.75 average price target.
See the top stocks recommended by analysts >>
Sierra Metals (SMTS)
In a report released today, Mark Reichman from Noble Financial maintained a Buy rating on Sierra Metals, with a price target of $2.75. The company’s shares closed last Thursday at $0.81, close to its 52-week low of $0.77.
According to TipRanks.com, Reichman ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Sierra Metals has an analyst consensus of Moderate Buy, with a price target consensus of $2.31, representing a 192.4% upside. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $3.50 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RKDA:
- Analysts Are Bullish on These Services Stocks: Harte-Hanks (HHS), Kelly Services (KELYA)
- Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Lineage Cell Therapeutics (LCTX) and Sarepta Therapeutics (SRPT)
- Analysts Offer Insights on Financial Companies: P10 Holdings (PX), Air Lease (AL) and Ryan Specialty Group (RYAN)
- Affirm Stock: Will it be a Long-Term Winner?
- Jefferies Thinks Nagarro SE’s Stock is Going to Recover
